New insights into the mechanisms behind how cancer-causing agents in the environment activate genetic recombination in DNA could help to explain some of the effects of exposure as well as predicting which individuals may ...
Nov 17, 2020
0
62
A comparison of two key research tools used by immunologists to study different types of T-cell receptor signals has identified important features of existing technologies that could allow scientists to better understand ...
Nov 4, 2020
0
31
A new study from the University of Birmingham has found that 50% of patients with a rare type of cancer that has spread into the lining of their abdomen may be suitable for immunotherapy treatment.
Nov 3, 2020
0
38
The processes our brains use to avoid harming other people are automatic and reflexive—and quite different from those used when avoiding harm to ourselves, according to new research.
Oct 15, 2020
0
645
A method for detecting traumatic brain injury at the point of care has been developed by scientists at the University of Birmingham.
Oct 13, 2020
0
87
Healthcare workers who self-isolated after developing symptoms of COVID-19 were more likely to have a vitamin D deficiency, with workers from Black, Asian or ethnic minority backgrounds particularly affected, a new study ...
Oct 7, 2020
2
4148
Proposals made by the government as part of Operation Moonshot could do more harm than good, a group of UK experts have argued in a new article published today by the BMJ.
Sep 23, 2020
0
62
Patients could benefit from faster and more effective introduction of artificial intelligence (AI) innovations to diagnose and treat disease—thanks to the first international standards for reporting of clinical trials for ...
Sep 10, 2020
0
155
A type of virus that preys on bacteria could be harnessed to combat bacterial infections in patients whose immune systems have been weakened by the SARS-CoV-2 virus that causes the COVID-19 disease, according to an expert ...
Jun 24, 2020
0
209
A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium.
Apr 23, 2020
0
110
